Literature DB >> 14592231

Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers.

Meir H Kryger1, Kazuo Otake, John Foerster.   

Abstract

BACKGROUND: It has been shown that restless legs syndrome (RLS) in adults may be linked to abnormalities in iron stores. Whether reduced iron stores play a role in children is not clear.
METHODS: We evaluated the status of iron stores and sleep in three teenagers who presented with severe sleep onset insomnia, subjective sleep latency exceeding 60 min and excessive daytime sleepiness.
RESULTS: The three teenagers were found to have RLS and laboratory evaluation confirmed reduced body stores of iron with a low percent iron saturation (mean value 9.7%) and a low serum ferritin level (mean value 17 microg/l). None had marked anemia. The three patients were treated with oral iron for 4-5 months. As a group they had an increase in percent iron saturation (from a mean of 9.7 to 22.7%) and serum ferritin (from a mean of 17 to 27 microg/l) and a marked reduction of the symptoms of RLS, with mean subjective sleep latency decreasing from 143 to 23 min, sleep efficiency increasing from 75.7 to 84.0% and the number of periodic movements per hour of sleep decreasing from 20.5 to 10.5.
INTERPRETATION: These findings support the hypothesis that abnormal iron stores or metabolism may result in RLS causing insomnia in teenagers. We recommend evaluation of iron status including serum iron, total iron binding capacity and ferritin levels in teenagers with chronic insomnia of unexplained origin even when anemia is mild or absent.

Entities:  

Year:  2002        PMID: 14592231     DOI: 10.1016/s1389-9457(01)00160-5

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  24 in total

1.  Assessment and treatment of common pediatric sleep disorders.

Authors:  Sricharan Moturi; Kristin Avis
Journal:  Psychiatry (Edgmont)       Date:  2010-06

2.  Polysomnographic characteristics of a referred sample of children with sickle cell disease.

Authors:  Valerie E Rogers; Daniel S Lewin; Glenna B Winnie; Jeanne Geiger-Brown
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

3.  Use of polysomnography with synchronized digital video recording to diagnose pediatric sleep breathing disorders.

Authors:  Katsuhisa Banno; Meir H Kryger
Journal:  CMAJ       Date:  2005-07-05       Impact factor: 8.262

4.  Restless legs syndrome, sleep, and quality of life among adolescents and young adults.

Authors:  Graciela E Silva; James L Goodwin; Kimberly D Vana; Monica M Vasquez; Peter G Wilcox; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2014-07-15       Impact factor: 4.062

Review 5.  Current treatment of selected pediatric sleep disorders.

Authors:  Shannon S Sullivan
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

Review 6.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

7.  Ferritin and iron levels in children with autistic disorder.

Authors:  Sabri Hergüner; Fatih Mehmet Keleşoğlu; Cansaran Tanıdır; Mazlum Cöpür
Journal:  Eur J Pediatr       Date:  2011-06-04       Impact factor: 3.183

8.  Pharmacological Management of Restless Legs Syndrome and Periodic Limb Movement Disorder in Children.

Authors:  Geoffrey Rulong; Thomas Dye; Narong Simakajornboon
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

9.  The iron status of children and youth in a community mental health clinic is lower than that of a national sample.

Authors:  Rhoda J Gottfried; Joan P Gerring; Kyla Machell; Gayane Yenokyan; Mark A Riddle
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03-12       Impact factor: 2.576

10.  Parental symptom report and periodic limb movements of sleep in children.

Authors:  Bradley T Martin; Bruce D Williamson; Natalie Edwards; Arthur Y Teng
Journal:  J Clin Sleep Med       Date:  2008-02-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.